High expression of transmembrane P24 trafficking protein 9 predicts poor prognosis in breast carcinoma
Over the years, molecular subtypes based on estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER-2) status have been observed to effectively guide decision-making for the optimal treatment of patients with breast carcinoma (BRCA). However, despite thi...
Guardado en:
Autores principales: | Gaoda Ju, Cheng Xu, Kai Zeng, Tianhao Zhou, Lijuan Zang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/59a7f861782b402a84825e51679dbc95 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Filamin-A expression in triple-negative breast cancer and its clinical significance
por: Abderrahman Ouban
Publicado: (2021) -
Aryl hydrocarbon receptor is a prognostic biomarker and is correlated with immune responses in cervical cancer
por: Jiasui Wang, et al.
Publicado: (2021) -
Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis
por: Yuexian Li, et al.
Publicado: (2021) -
Glycolysis related gene expression signature in predicting prognosis of laryngeal squamous cell carcinoma
por: Hui-Ching Lau, et al.
Publicado: (2021) -
Identification of circRNA_001846 as putative non–small cell lung cancer biomarker
por: Fan Yang, et al.
Publicado: (2021)